Marek's disease virus: from miasma to model

被引:339
作者
Osterrieder, N [1 ]
Kamil, JP [1 ]
Schumacher, D [1 ]
Tischer, BK [1 ]
Trapp, S [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA
关键词
D O I
10.1038/nrmicro1382
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Marek's disease virus (MDV) is an oncogenic herpesvirus that causes various clinical syndromes in its natural host, the chicken. MDV has long been of interest as a model organism, particularly with respect to the pathogenesis and immune control of virus-induced lymphoma in an easily accessible small-animal system. Recent advances in MDV genetics and the determination of the chicken genome sequence, aided by functional genomics, have begun to dramatically increase our understanding not only of lytic MDV replication, but also of the factors and mechanisms leading to latency and tumour formation. This new information is helping to elucidate cellular signalling pathways that have undergone convergent evolution and are perturbed by different viruses, and emphasizes the value of MDV as a comparative biomedical model. Furthermore, the door is now open for rational and efficient engineering of new vaccines against one of the most important and widespread infectious diseases in chickens.
引用
收藏
页码:283 / 294
页数:12
相关论文
共 136 条
[21]   IMMUNIZATION AGAINST MAREKS DISEASE USING A LIVE ATTENUATED VIRUS [J].
CHURCHILL, AE ;
PAYNE, LN ;
CHUBB, RC .
NATURE, 1969, 221 (5182) :744-+
[22]  
CHURCHILL AE, 1968, JNCI-J NATL CANCER I, V41, P939
[23]   AGENT OF MAREKS DISEASE IN TISSUE CULTURE [J].
CHURCHILL, AE ;
BIGGS, PM .
NATURE, 1967, 215 (5100) :528-+
[24]  
CHURCHILL AE, 1968, JNCI-J NATL CANCER I, V41, P951
[25]   A Marek's disease virus vIL-8 deletion mutant has attenuated virulence and confers protection against challenge with a very virulent plus strain [J].
Cui, XP ;
Lee, LF ;
Hunt, HD ;
Reed, WM ;
Lupiani, B ;
Reddy, SM .
AVIAN DISEASES, 2005, 49 (02) :199-206
[26]   Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency [J].
Cui, XP ;
Lee, LF ;
Reed, WM ;
Kung, HJ ;
Reddy, SM .
JOURNAL OF VIROLOGY, 2004, 78 (09) :4753-4760
[27]  
Davison A, 2002, VIRUS RES, V82, P127
[28]   Evolution of the herpesviruses [J].
Davison, AJ .
VETERINARY MICROBIOLOGY, 2002, 86 (1-2) :69-88
[29]   PROTECTIVE EFFICACY OF MAREKS-DISEASE VIRUS (MDV) CVI-988 CEF65 CLONE-C AGAINST CHALLENGE INFECTION WITH 3 VERY VIRULENT MDV STRAINS [J].
DEBOER, GF ;
GROENENDAL, JE ;
BOERRIGTER, HM ;
KOK, GL ;
POL, JMA .
AVIAN DISEASES, 1986, 30 (02) :276-283
[30]   LATENT MAREKS-DISEASE VIRUS CAN BE ACTIVATED FROM ITS CHROMOSOMALLY INTEGRATED STATE IN HERPESVIRUS-TRANSFORMED LYMPHOMA-CELLS [J].
DELECLUSE, HJ ;
SCHULLER, S ;
HAMMERSCHMIDT, W .
EMBO JOURNAL, 1993, 12 (08) :3277-3286